199 related articles for article (PubMed ID: 15895232)
1. Platinum-acridinylthiourea conjugates show cell line-specific cytotoxic enhancement in H460 lung carcinoma cells compared to cisplatin.
Hess SM; Mounce AM; Sequeira RC; Augustus TM; Ackley MC; Bierbach U
Cancer Chemother Pharmacol; 2005 Oct; 56(4):337-43. PubMed ID: 15895232
[TBL] [Abstract][Full Text] [Related]
2. Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin.
O'Neill CF; Koberle B; Masters JR; Kelland LR
Br J Cancer; 1999 Dec; 81(8):1294-303. PubMed ID: 10604725
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, biological activity, and DNA-damage profile of platinum-threading intercalator conjugates designed to target adenine.
Guddneppanavar R; Saluta G; Kucera GL; Bierbach U
J Med Chem; 2006 Jun; 49(11):3204-14. PubMed ID: 16722638
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships in platinum-acridinylthiourea conjugates: effect of the thiourea nonleaving group on drug stability, nucleobase affinity, and in vitro cytotoxicity.
Ackley MC; Barry CG; Mounce AM; Farmer MC; Springer BE; Day CS; Wright MW; Berners-Price SJ; Hess SM; Bierbach U
J Biol Inorg Chem; 2004 Jun; 9(4):453-61. PubMed ID: 15067524
[TBL] [Abstract][Full Text] [Related]
5. Solution structural study of a DNA duplex containing the guanine-N7 adduct formed by a cytotoxic platinum-acridine hybrid agent.
Baruah H; Wright MW; Bierbach U
Biochemistry; 2005 Apr; 44(16):6059-70. PubMed ID: 15835895
[TBL] [Abstract][Full Text] [Related]
6. Unprecedented monofunctional metalation of adenine nucleobase in guanine- and thymine-containing dinucleotide sequences by a cytotoxic platinum-acridine hybrid agent.
Barry CG; Baruah H; Bierbach U
J Am Chem Soc; 2003 Aug; 125(32):9629-37. PubMed ID: 12904029
[TBL] [Abstract][Full Text] [Related]
7. Effect of the diamine nonleaving group in platinum-acridinylthiourea conjugates on DNA damage and cytotoxicity.
Guddneppanavar R; Choudhury JR; Kheradi AR; Steen BD; Saluta G; Kucera GL; Day CS; Bierbach U
J Med Chem; 2007 May; 50(9):2259-63. PubMed ID: 17408248
[TBL] [Abstract][Full Text] [Related]
8. DNA minor groove adducts formed by a platinum-acridine conjugate inhibit association of tata-binding protein with its cognate sequence.
Budiman ME; Bierbach U; Alexander RW
Biochemistry; 2005 Aug; 44(33):11262-8. PubMed ID: 16101310
[TBL] [Abstract][Full Text] [Related]
9. Duplex-promoted platination of adenine-N3 in the minor groove of DNA: challenging a longstanding bioinorganic paradigm.
Barry CG; Day CS; Bierbach U
J Am Chem Soc; 2005 Feb; 127(4):1160-9. PubMed ID: 15669855
[TBL] [Abstract][Full Text] [Related]
10. Influence of a novel platinum compound--cis-dichloro (dimethylsulphoxide) (1-beta-D-rybofuranosyl-1,2,4-triazolo-3-arboxyamide) platinum (II)--"Pt-rib-1"--on cell cycle and apoptosis in ClS91 and B16 mouse melanoma in vitro.
Drewa T; Olszewska-Słonina D; Woźniak A; Styczyński J; Drewa G; Szłyk E; Lakomska I; Kobe J; Czajkowski R
Acta Pol Pharm; 2004; 61(1):39-44. PubMed ID: 15259856
[TBL] [Abstract][Full Text] [Related]
11. Palladium(II) and platinum(II) organometallic complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor activity of the platinum compounds.
Ruiz J; Villa MD; Cutillas N; López G; de Haro C; Bautista D; Moreno V; Valencia L
Inorg Chem; 2008 Jun; 47(11):4490-505. PubMed ID: 18447329
[TBL] [Abstract][Full Text] [Related]
12. A non-crosslinking platinum-acridine hybrid agent shows enhanced cytotoxicity compared to clinical BCNU and cisplatin in glioblastoma cells.
Hess SM; Anderson JG; Bierbach U
Bioorg Med Chem Lett; 2005 Jan; 15(2):443-6. PubMed ID: 15603970
[TBL] [Abstract][Full Text] [Related]
13. Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines.
Mamenta EL; Poma EE; Kaufmann WK; Delmastro DA; Grady HL; Chaney SG
Cancer Res; 1994 Jul; 54(13):3500-5. PubMed ID: 8012973
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
[TBL] [Abstract][Full Text] [Related]
15. Accumulation, platinum-DNA adduct formation and cytotoxicity of cisplatin, oxaliplatin and satraplatin in sensitive and resistant human osteosarcoma cell lines, characterized by p53 wild-type status.
Martelli L; Di Mario F; Botti P; Ragazzi E; Martelli M; Kelland L
Biochem Pharmacol; 2007 Jun; 74(1):20-7. PubMed ID: 17466278
[TBL] [Abstract][Full Text] [Related]
16. Unique base-step recognition by a platinum-acridinylthiourea conjugate leads to a DNA damage profile complementary to that of the anticancer drug cisplatin.
Budiman ME; Alexander RW; Bierbach U
Biochemistry; 2004 Jul; 43(26):8560-7. PubMed ID: 15222767
[TBL] [Abstract][Full Text] [Related]
17. Platinum(IV) complex with adamantylamine overcomes intrinsic resistance to cisplatin in ovarian cancer cells.
Horváth V; Blanárová O; Svihálková-Sindlerová L; Soucek K; Hofmanová J; Sova P; Kroutil A; Fedorocko P; Kozubík A
Gynecol Oncol; 2006 Jul; 102(1):32-40. PubMed ID: 16364413
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and activity of a trinuclear platinum complex: [{trans-PtCl(NH3)2}2mu-{trans-Pt(3-hydroxypyridine)2(H2N(CH2)6NH2)2}]Cl4 in ovarian cancer cell lines.
Tayyem H; Huq F; Yu JQ; Beale P; Fisher K
ChemMedChem; 2008 Jan; 3(1):145-51. PubMed ID: 17963210
[TBL] [Abstract][Full Text] [Related]
19. ATP sensitizes H460 lung carcinoma cells to cisplatin-induced apoptosis.
Swennen EL; Ummels V; Buss I; Jaehde U; Bast A; Dagnelie PC
Chem Biol Interact; 2010 Mar; 184(3):338-45. PubMed ID: 20156429
[TBL] [Abstract][Full Text] [Related]
20. 7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel synthetic compound induces lung carcinoma cell death associated with inhibiting ERK and CDC2 phosphorylation via a p53-independent pathway.
Hsu TS; Chen C; Lee PT; Chiu SJ; Liu HF; Tsai CC; Chao JI
Cancer Chemother Pharmacol; 2008 Oct; 62(5):799-808. PubMed ID: 18193228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
